GlaxoSmithKline reported 24.17B in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Alcon AG ALC:SW 4.48B 16M
AstraZeneca AZN:LN 30781M 1131M
Bayer BAYN:GR € 40872M 894M
Fresenius FRE:GR € 27155M 36M
Galapagos GLPG:NA € 26.86M 0.47M
Genmab GEN:DC DK 416M 9M
GRIFOLS GRF:SM € 7933.89M 565.82M
Hikma Pharmaceutical HIK:LN 846M 86M
Lonza Group LONN:SW 2.4B 1.24B
Novartis NOVN:VX SF 31025M 3218M
Orion ORNBV:FH € 108.5M 0.5M
Philips PHIA:NA € 6979M 655M
Recordati REC:IM € 1066.35M 81.21M